Latest publications

Conjunctivitis Occurring in Atopic Dermatitis Patients Treated with Dupilumab - Clinical Characteristics and Treatment. Wollenberg A, Ariens L, Thurau S, Van Luijk C, Seegräber M, De Bruin-Weller M et al. J Allergy Clin Immunol Pract 2018 Feb 09

Serum biomarker profiles suggest that atopic dermatitis is a systemic disease. Thijs JL, Strickland I, Bruijnzeel-Koomen CAFM, Nierkens S, Giovannone B, Knol EF et al. J. Allergy Clin. Immunol. 2018 Feb 01

Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study. Van den Reek JMPA, Van Vugt LJ, Van Doorn MBA, Van der Kraaij GE, De Kort WJA, Lucker GPH et al. Acta Derm. Venereol. 2018 Feb 06

Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with Demodex and increased IL-17 levels? Reply from authors. De Bruin-Weller M, Graham NMH, Pirozzi G, Shumel B et al. Br. J. Dermatol. 2018 Jan 15

Epidemiology of atopic dermatitis in adults: Results from an international survey. Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL et al. Allergy 2018 Jan 10

Parental treatment management skills in paediatric atopic dermatitis. Fieten KB, Bruins FM, Zijlstra WT, Schappin R, Figee L, De Bruijn M et al. Clin. Exp. Dermatol. 2017 Dec 20

Sensitization to PR-10 proteins is indicative of distinctive sensitization patterns in adults with a suspected food allergy. Blankestijn MA, Knulst AC, Knol EF, Le TM, Rockmann H, Otten HG et al. Clin Transl Allergy 2017; 7:42

Dupilumab with concomitant topical corticosteroids in adult patients with atopic dermatitis who are not adequately controlled with or are intolerant to ciclosporin A, or when this treatment is medically inadvisable: a placebo-controlled, randomized phase 3 clinical trial (LIBERTY AD CAFÉ). De Bruin-Weller M, Thaçi D, Smith CH, Reich K, Cork M, Radin A et al. Br. J. Dermatol. 2017 Nov 28

Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial. Sampson HA, Shreffler WG, Yang WH, Sussman GL, Brown-Whitehorn TF, Nadeau KC et al. JAMA 2017 11 14; 318(18):1798-1809

Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema. Garritsen FM, Van der Schaft J, De Graaf M, Hijnen DJ, Bruijnzeel-Koomen CAF, Van den Broek MPH et al. Acta Derm. Venereol. 2017 Nov 14

Effectiveness of alpine climate treatment for children with difficult to treat atopic dermatitis: Results of a pragmatic randomized controlled trial (DAVOS trial). Fieten KB, Schappin R, Zijlstra WT, Figee L, Beutler J, Raymakers F et al. Clin. Exp. Allergy 2018 Feb; 48(2):186-195

Short term effectiveness and experiences of a peer guided web-based self-management intervention for young adults with juvenile idiopathic arthritis. Ammerlaan J, Van Os-Medendorp H, De Boer-Nijhof N, Scholtus L, Kruize AA, Van Pelt P et al. Pediatr Rheumatol Online J 2017 Oct 13; 15(1):75

Component-resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy. Datema MR, Van Ree R, Asero R, Barreales L, Belohlavkova S, De Blay F et al. Allergy 2018 Mar; 73(3):549-559

Is there an increased risk of cervical neoplasia in atopic dermatitis patients treated with oral immunosuppressive drugs? Garritsen FM, Verheijen RHM, Gerestein CG, Van Zuilen AD, Oosterhaven JAF, Van Dijk M et al. J Eur Acad Dermatol Venereol 2018 Feb; 32(2):271-275

Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine. Garritsen FM, Van der Schaft J, Bruijnzeel-Koomen CAF, Van Schaik RH, De Graaf M, Van den Broek MPH et al. J Dermatolog Treat 2017 Sep 26:1-8